{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:04:33Z","timestamp":1770271473594,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2004,1,14]],"date-time":"2004-01-14T00:00:00Z","timestamp":1074038400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1007\/s00296-003-0422-0","type":"journal-article","created":{"date-parts":[[2004,7,22]],"date-time":"2004-07-22T00:55:38Z","timestamp":1090457738000},"page":"211-214","source":"Crossref","is-referenced-by-count":24,"title":["Experience with monthly, high-dose, intravenous immunoglobulin therapy in patients with different connective tissue diseases"],"prefix":"10.1007","volume":"25","author":[{"given":"Sevil","family":"Kamali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse","family":"Cefle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Sayarlioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Gul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Inanc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lale","family":"Ocal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orhan","family":"Aral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meral","family":"Konice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,1,14]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0140-6736(85)90400-3","volume":"2","author":"Imbach","year":"1985","unstructured":"Imbach P, Wagner H, Berchtold W et al (1985) Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood. Lancet 2:464","journal-title":"Lancet"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJM199106063242305","volume":"324","author":"Newburger","year":"1991","unstructured":"Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J et al (1991) A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324:1633?1639","journal-title":"N Engl J Med"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0002-9343(91)90010-U","volume":"91","author":"Lang","year":"1991","unstructured":"Lang BA, Laxer RM, Murphy G, Silverman ED, Roifman CM (1991) Treatment of dermatomyositis with intravenous gammaglobulin. Am J Med 91:169?172","journal-title":"Am J Med"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","volume":"325","author":"Dalakas","year":"1991","unstructured":"Dalakas MC (1991) Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 325:1487?1498","journal-title":"N Engl J Med"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/rheumatology\/41.1.7","volume":"411","author":"Choy","year":"2002","unstructured":"Choy EH, Isenberg DA (2002) Treatment of dermatomyositis and polymyositis. Rheumatology 411:7?13","journal-title":"Rheumatology"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/art.10053","volume":"46","author":"Cherin","year":"2002","unstructured":"Cherin P, Pelletier S, Teixeira A, Laforet P, Genereau T, Simon A, Maisonobe T, Eymard B, Herson S (2002) Results and long-term follow-up of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients. Arthritis Rheum 46:467?474","journal-title":"Arthritis Rheum"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2133.1994.tb02906.x","volume":"130","author":"Collet","year":"191994","unstructured":"Collet E, Dalac S, Maerens B, Courtois JM, Izac M, Lambert D (191994) Juvenile dermatomyositis: treatment with intravenous gammaglobulin. Br J Dermatol 130:231?234","journal-title":"Br J Dermatol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1191\/096120399678841007","volume":"8","author":"Levy","year":"1999","unstructured":"Levy Y, Sherer Y, Ahmed A, Langevitz P, George J et al (1999) A study of 20 patients with intravenous immunoglobulin?clinical and serologic response. Lupus 8:705?712","journal-title":"Lupus"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0049-0172(00)80018-9","volume":"29","author":"Levy","year":"2000","unstructured":"Levy Y, Sherer Y, George J, Rovensky J, Lukac J et al (2000) Intravenous immunoglobulin treatment of lupus nephritis. Semin Arthritis Rheum 29:321?327","journal-title":"Semin Arthritis Rheum"},{"key":"CR10","first-page":"314","volume":"26","author":"Palla","year":"1986","unstructured":"Palla R, Cirami C, Bionda A et al (1986) High dose intravenous gammaglobulin for membranous nephropathy. Clin Nephrol 26:314","journal-title":"Clin Nephrol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(99)01575-5","volume":"354","author":"Boletis","year":"1999","unstructured":"Boletis JN, Ioannidis JPA, Boki KA, Moutsopoulos HM (1999) Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis. Lancet 354:569?570","journal-title":"Lancet"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0140-6736(88)92859-0","volume":"2","author":"Carreras","year":"1988","unstructured":"Carreras LO, Perez GN, Vega HR, Casavilla F (1988) Lupus anticoagulant and recurrent fatal loss: successful treatment with gammaglobulin. Lancet 2:393?394","journal-title":"Lancet"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/rheumatology\/39.4.421","volume":"39","author":"Sherer","year":"2000","unstructured":"Sherer Y, Levy Y, Shoenfeld Y (2000) Intravenous immunoglobulin therapy of antiphospholipid syndrome. Rheumatology 39:421?426","journal-title":"Rheumatology"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0002-9378(00)70500-X","volume":"182","author":"Branch","year":"2000","unstructured":"Branch D, Ware MD, Peaceman AM et al (2000) A multicenter, placebo controlled pilot study of intravenous treatment of antiphospholipid syndrome during pregnancy. Am J Obstet Gynecol 182:122?127","journal-title":"Am J Obstet Gynecol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/rheumatology\/35.11.1150","volume":"35","author":"Jayne","year":"1996","unstructured":"Jayne DRW, Lockwood CM (1996) Intravenous immunoglobulin as sole therapy for systemic vasculitis. Br J Rheumatol 35:1150?1153","journal-title":"Br J Rheumatol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/qjmed\/93.7.433","volume":"93","author":"Jayne","year":"2000","unstructured":"Jayne DRW, Chapel H, Adu D, Misbah S, O?Donoghue D, Scott D (2000) Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. QJM 93:433?49","journal-title":"QJM"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0248-8663(96)80703-X","volume":"16","author":"Permal","year":"1995","unstructured":"Permal S, Wechsler B, Cabane J, Perrot S, Blum L, Imbert JC (1995) Treatment of Still disease in adults with intravenous immunoglobulins. Rev Med Interne 16:250?254","journal-title":"Rev Med Interne"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","volume":"345","author":"Kazatchkine","year":"2001","unstructured":"Kazatchkine MD, Kaveri SV (2001) Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 345:747?755","journal-title":"N Engl J Med"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"Tan","year":"1982","unstructured":"Tan EM (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271?1277","journal-title":"Arthritis Rheum"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","volume":"33","author":"Leavitt","year":"1990","unstructured":"Leavitt RY et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener?s granulomatosis. Arthritis Rheum 33:1101?1107","journal-title":"Arthritis Rheum"},{"key":"CR21","doi-asserted-by":"crossref","unstructured":"Dalakas MC (1988) A classification of polymyositis and dermatomyositis. In: Dalakas MC (ed) Polymyositis and dermatomyositis. Butterworth, Boston, pp\ufffd1?16","DOI":"10.1016\/B978-0-409-95191-2.50005-7"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/rheumatology\/41.4.367","volume":"41","author":"Pyne","year":"2002","unstructured":"Pyne D, Ehrenstein M, Morris V (2002) The therapeutic uses of intravenous immunoglobulins in autoimmune rheumatic diseases. Rheumatology 41:367?374","journal-title":"Rheumatology"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/art.1780330825","volume":"33","author":"Maier","year":"1990","unstructured":"Maier WP, Gordon DS, Howard RF, Saleh MN, Miller SB et al (1990) Intravenous immunoglobulin therapy in systemic lupus erythematosus-associated thrombocytopenia. Arthritis Rheum 33:1233?1239","journal-title":"Arthritis Rheum"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/BF00320256","volume":"59","author":"Jacobs","year":"1989","unstructured":"Jacobs P, Wood L (1989) The comparison of gammaglobulin to steroids in treating adult immune thrombocytopenia: an interim analysis. Blut 59:92?95","journal-title":"Blut"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s100670050079","volume":"18","author":"Sherer","year":"1999","unstructured":"Sherer Y, Levy Y, Langevitz P, Lorber M, Fabrizzi F, Shoenfeld Y (1999) Successful treatment of systemic lupus erythematosus cerebritis with intravenous immunoglobulin. Clin Rheumatol 18:170?173","journal-title":"Clin Rheumatol"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/art.1780400426","volume":"40","author":"Lafferty","year":"1997","unstructured":"Lafferty TE, Smith JB, Schuster SJ, De Horatius RJ (1997) Treatment of acquired factor VIII inhibitor using intravenous immunoglobulin in two patients with systemic lupus erythematosus. Arthritis Rheum 40:775?778","journal-title":"Arthritis Rheum"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1177\/096120339700600412","volume":"6","author":"Aharon","year":"1997","unstructured":"Aharon A, Levy Y, Bar-Dayan Y, Afek A, Zandman-Goddard G, Skurnik Y, Fabrizzi F, Shoenfeld Y (1997) Successful treatment of early secondary myelofibrosis in SLE with IVIG. Lupus 6:408?411","journal-title":"Lupus"},{"key":"CR28","doi-asserted-by":"crossref","unstructured":"Kurth R, Haas WH (2002) Epidemiology, diagnostic possibilities, and treatment of tuberculosis. Ann Rheum Dis 61 [Suppl\ufffd2]:ii59?ii61","DOI":"10.1136\/ard.61.suppl_2.ii59"},{"key":"CR29","doi-asserted-by":"crossref","unstructured":"Dalakas MC (1998) Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body myositis, and polymyositis. Neurology 51 [6 Suppl\ufffd5]:S37?S45","DOI":"10.1212\/WNL.51.6_Suppl_5.S37"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/0091-6749(91)90195-T","volume":"88","author":"Hamilos","year":"1991","unstructured":"Hamilos DL, Christensen J (1991) Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulin. J Allergy Clin Immunol 88:823?824","journal-title":"J Allergy Clin Immunol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000024199","volume":"119","author":"Levy","year":"1999","unstructured":"Levy Y, Sherer Y, George J, Langevitz P, Ahmed A, Bar-Dayan Y, Fabrizzi F, Terryberry J, Peter J, Shoenfeld Y (1999) Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune disease with intravenous immunoglobulin. Int Arch Allergy Immunol 119:231?238","journal-title":"Int Arch Allergy Immunol"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1075-4210(99)90011-1","volume":"5","author":"Epstein","year":"1999","unstructured":"Epstein JS, Gaines A, Kapit R, Pierce R, Potter R, Varricchio F (1999) Important drug information: immune globulin intravenous (human). Int J Trauma Nurs 5:139?140","journal-title":"Int J Trauma Nurs"},{"key":"CR33","first-page":"673","volume":"14","author":"Hashkes","year":"1996","unstructured":"Hashkes PJ, Lovell DJ (1996) Vasculitis in systemic lupus erythematosus following intravenous immunoglobulin therapy. Clin Exp Rheumatol 14:673?675","journal-title":"Clin Exp Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-003-0422-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-003-0422-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-003-0422-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:15:14Z","timestamp":1559042114000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-003-0422-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1,14]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["422"],"URL":"https:\/\/doi.org\/10.1007\/s00296-003-0422-0","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1,14]]}}}